FAM221A antibody (AA 201-298)
Quick Overview for FAM221A antibody (AA 201-298) (ABIN1713436)
Target
See all FAM221A AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 201-298
-
Purpose
- C7orf46 Polyclonal Antibody
-
Cross-Reactivity
- Human
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human C7orf46
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB(1:300-5000),
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- FAM221A (Family with Sequence Similarity 221, Member A (FAM221A))
-
Alternative Name
- C7orf46
-
Background
-
Synonyms: C7orf46, F221A_HUMAN, Chromosome 7 open reading frame 46, Uncharacterized protein C7orf46.
Background: Chromosome 7 has been linked to Osteogenesis imperfecta, Pendred syndrome, Lissencephaly, Citrullinemia and Shwachman-Diamond syndrome. The deletion of a portion of the q arm of chromosome 7 is associated with Williams-Beuren syndrome, a condition characterized by mild mental retardation, an unusual comfort and friendliness with strangers and an elfin appearance. Deletions of portions of the q arm of chromosome 7 are also seen in a number of myeloid disorders including cases of acute myelogenous leukemia and myelodysplasia. The C7orf46 gene product has been provisionally designated C7orf46 pending further characterization.
Target
-